Traversing a wormhole to combat Parkinson's disease

DMM Disease Models and Mechanisms

Volumn 1, Issue 1, 2008, Pages 32-36

  Caldwell, Guy A ^a,b   Caldwell, Kim A ^a,b  

^a UNIVERSITY OF ALABAMA   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT; DOPAMINE;

CAENORHABDITIS ELEGANS; CELL FUNCTION; DOPAMINERGIC NERVE CELL; GENOME; HUMAN; LIFESPAN; MICROSCOPY; NERVE DEGENERATION; NERVOUS SYSTEM; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; REVIEW; ANIMAL; ANIMAL MODEL; ARTICLE; BIOSYNTHESIS; GENETIC PREDISPOSITION; GENETICS; METABOLISM; NERVE CELL; PATHOPHYSIOLOGY;

ANIMALIA; CAENORHABDITIS ELEGANS; NEMATODA;

ANIMALS; CAENORHABDITIS ELEGANS; DOPAMINE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MODELS, ANIMAL; NEURONS; PARKINSON DISEASE;

EID: 64249149489     PISSN: 17548403     EISSN: 17548411     Source Type: Journal    
DOI: 10.1242/dmm.000257     Document Type: Review

References (39)

1. Aharon-Peretz, J., Rosenbaum, H. and Gershoni- Baruch, R. (2004). Mutations in the glucocerebrosidase gene and Parkinson's disease in Ashkenazi Jews. New Engl. J. Med. 351, 1972-1977.
2. Augood, S. J., Penney, J. B., Jr, Friberg, I. K., Breakefield, X. O., Young, A. B., Ozelius, L. J. and Standaert, D. G. (1998). Expression of the early-onset torsion dystonia gene (DYT1) in human brain. Ann. Neurol. 43, 669-673. (Pubitemid 28225561)
3. Bargmann, C. I. (1998). Neurobiology of the C. elegans. Genome Science 282, 2028-2033.
4. Braungart, E., Gerlach, M, Riederer, P., Baumeister, R. and Hoener, M. C. (2004). Caenorhabditis elegans MPP+ model of Parkinson's disease for highthroughput drug screenings. Neurodegener Dis. 1, 175-183. (Pubitemid 39551794)
5. Caldwell, G. A., Cao, S., Sexton, E. G., Gelwix, C. C., Bevel, J. P. and Caldwell, K. A. (2003). Suppression of polyglutamine-induced protein aggregation in Caenorhabditis elegans by torsin proteins. Hum. Molec. Genet. 12, 307-319. (Pubitemid 36204427)
6. Cao, S., Gelwix, C. C., Caldwell, K. A. and Caldwell, G. A. (2005). Torsin-mediated protection from cellular stress in the domaminergic neurons of Caenorhabditis elegans. J. Neurosci. 12, 3801-3812. (Pubitemid 40570413)
7. Chase, D. L., Pepper, J. S. and Koelle, M. R. (2004). Mechanism of extrasynaptic dopamine signaling in Caenorhabditis elegans. Nat. Neurosci. 7, 1096-1103. (Pubitemid 41184450)
8. Clark, I. E., Dodson, M. W., Jiang, C., Cao, J. H., Huh, J. R., Seol, J. H., Yoo, S. J., Hay, B. A. and Guo, M. (2006). Drosophila pink1 is required for mitochondrial function and interacts genetically with parkin. Nature 441, 1162-1166. (Pubitemid 43990738)
9. Clark, L. N., Ross, B. M., Wang, Y., Mejia-Santana, H., Harris, J., Louis, E. D., Cote, L. J., Andrews, H., Fahn, S., Waters, C. et al. (2007). Mutations in the glucocerebrosidase gene are associated with earlyonset Parkinson's disease. Neurology 69, 1270-1277. (Pubitemid 47429028)
10. Cooper, A. A., Gitler, A. D., Cashikar, A., Haynes, C. M., Hill, K. J., Bhullar, B., Liu, K., Xu, K., Strathearn, K. E., Liu, F. et al. (2006). Alpha-synuclein blocks ER-Golgi traffic and Rab1 rescues neuron loss in Parkinson's models. Science 313, 324-328. (Pubitemid 44480951)
11. Fung, H. C., Scholz, S., Matarin, M., Simon-Sanchez, J., Hernandez, D., Britton, A., Gibbs, J. R., Langefeld, C., Stiegert, M. L., Schymick, J. et al. (2006). Genomewide genotyping in Parkinson's disease and neurologically normal controls: first stage analysis and public release of data. Lancet 5, 911-916. (Pubitemid 44556544)
12. Gitler, A. D., Bevis, B. J., Shorter, J., Strathearn, K. E., Hamamichi, S., Su, L. J., Caldwell, K. A., Caldwell, G. A., Rochet, J. C., McCaffery, J. M. et al. (2008). The Parkinson's disease protein alpha-synuclein disrupts cellular Rab homeostasis. Proc. Natl. Acad. Sci. USA 105, 145-150.
13. Hamamichi, S., Rivas, R. N., Knight, A. L., Cao, S., Caldwell, K. A. and Caldwell, G. A. (2008). Hypothesis-based RNAi screening identifies neuroprotective genes in a Parkinson's disease model. Proc. Natl. Acad. Sci. USA 105, 728-733. (Pubitemid 351171776)
14. Kamath, R. S. and Ahringer, J. (2003). Genome-wide RNAi screening in Caenorhabditis elegans. Methods 30, 313-321.
15. Kenyon, C. (2005). The plasticity of aging: insights from long-lived mutants. Cell 120, 449-460.
16. Kim, D. H., Feinbaum, R., Alloing, G., Emerson, F. E., Garsin, D. A., Inoue, H., Tanaka-Hino, M., Hisamoto, N., Matsumoto, K., Tan, M. W. et al. (2002). A conserved p38 MAP kinase pathway in Caenorhabditis elegans innate immunity. Science 297, 623-626. (Pubitemid 34815350)
17. Kim, J., Inoue, K., Ishii, J., Vanti, W. B., Voronov, S. V., Murchison, E., Hannon, G. and Abeliovich, A. (2007). A microRNA feedback circuit in midbrain dopamine neurons. Science 317, 1220-1224.
18. Kosik, K. S. (2006). The neuronal microRNA system. Nat. Rev. Neurosci. 7, 911-920.
19. Kuwahara, T., Koyama, A., Gengyo-Ando, K., Masuda, M., Kowa, H., Tsunoda, M., Mitani, S. and Iwatsubo, T. (2006). Familial Parkinson mutant α-synuclein causes dopamine neuron dysfunction in transgenic Caenorhabditis elegans. J. Biol. Chem. 281, 334-340. (Pubitemid 43671193)
20. Lasko, M., Vartiainen, S., Moilanen, A.-M., Sirvio, J., Thomas, J. H., Nass, R., Blakley, R. D. and Wong, G. (2003). Dopaminergic neuronal loss and motor deficits in Caenorhabditis elegans overexpressing human α-synuclein. J. Neurochem. 86, 165-172. (Pubitemid 36753857)
21. Haugarvoll, K., Rademakers, R., Kachergus, J. M., Nuytemans, K., Ross, O. A., Gibson, J. M., Tan, E. K., Gaig, C., Tolosa, E., Goldwurm, S. et al. (2008). Lrrk2 R1441C parkinsonism is clinically similar to sporadic Parkinson disease. Neurology 70, 1456-1460.
22. Ibanez-Ventoso, C., Yang, M., Guo, S., Robins, H., Padgett, R. W. and Driscoll, M. (2006). Modulated microRNA expression during adult lifespan in Caenorhabditis elegans. Aging Cell 5, 235-246. (Pubitemid 43805613)
23. Maranova, M. and Nichols, C. D. (2007). Identification of neuroprotective compounds of Caenorhabditis elegans dopaminergic neurons against 6-OHDA. J. Mol. Neurosci. 31, 127-137.
24. Mohri-Shiomi, A. and Garsin, D. A. (2008). Insulin signaling and the heat shock response modulate protein homeostasis in the Caenorhabditis elegans intestine during infection. J. Biol. Chem. 283, 194-201.
25. Murphy, C. T., McCarroll, S. A., Bargmann, C. I., Fraser, A., Kamath, R. S., Ahringer, J., Li, H. and Kenyon, C. (2003). Genes that act downstream of DAF-16 to influence the lifespan of Caenorhabditis elegans. Nature 424, 277-283. (Pubitemid 36899363)
26. Nass, R., Hahn, M. K., Jessen, T., McDonald, P. W., Carvelli, L. and Blakely, R. D. (2005). A genetic screen in Caenorhabditis elegans for dopamine neuron insensitivity to 6-hydroxydopamine identifies dopamine transporter mutants impacting transporter biosynthesis and trafficking. J. Neurochem. 94, 774-785. (Pubitemid 41098509)
27. Nass, R., Hall, D. H., Miller, D. M., 3rd and Blakely, R. D. (2002). Neurotoxin-induced degeneration of dopamine neurons in Caenorhabditis elegans. Proc. Natl. Acad. Sci. USA 99, 3264-3269.
28. Panowski, S. H., Wolff, S., Aguilaniu, H., Durieux, J. and Dillin, A. (2007). HA-4/Foxa mediates dietrestriction- induced longevity of C. elegans. Nature 447, 550-555. (Pubitemid 46868041)
29. Park, J., Lee, S. B., Lee, S., Kim, Y., Song, S., Kim, S., Bae, E., Kim, J., Shong, M., Kim, J. M. et al. (2006). Mitochondrial dysfunction in Drosophila PINK1 mutants is complemented by parkin. Nature 441, 1157-1161. (Pubitemid 43990737)
30. Poole, A. C., Thomas, R. E., Andrews, L. A., McBride, H. M., Whitworth, A. J. and Pallanck, L. (2008). The PINK1/Parkin pathway regulates mitochondrial morphology. Proc. Natl. Acad. Sci. USA 105, 1638-1643.
31. Ramirez, A., Heimbach, A., Grundemann, J., Stiller, B., Hampshire, D., Cid, L. P., Goebel, I., Mubaidin, A. F., Wriekat, A. L., Roeper, J. et al. (2006). Hereditary parkinsonism with dementia is caused by mutations in ATP13A2, encoding a lysosomal type 5 P-type ATPase. Nat. Genet. 38, 1184-1191. (Pubitemid 44470365)
32. Sakaguchi-Nakashima, A., Meir, J. Y., Jin, Y., Matsumoto, K. and Hisamoto, N. (2007). LRK-1, a C. elegans PARK8-related kinase, regulates axonaldendritic polarity of SV proteins. Curr. Biol. 7, 592-598. (Pubitemid 46497793)
33. Sawin, E. R., Ranganathan, R. and Horvitz, H. R. (2000). C. elegans locomotory rate is modulated by the environment through a dopaminergic pathway and by experience through a serotonergic pathway. Neuron 26, 619-631. (Pubitemid 30953904)
34. Springer, W., Hoppe, T., Schmidt, E. and Baumeister, R. (2005). A Caenorhabditis elegans Parkin mutant with altered solubility couples alpha-synuclein aggregation to proteotoxic stress. Hum. Mol. Genet. 14, 3407-3423. (Pubitemid 41672125)
35. Tischler, J., Lenher, B. and Fraser, A. G. (2008). Evolutionary plasticity of gene networks. Nat. Genet. 4, 390-391.
36. van Ham, T. J., Thijssen, K. L., Breitling, R., Hofstra, R. M. W., Plasterk, R. H. A. and Nollen, E. A. A. (2008). C. elegans model identifies genetic modifiers of α-synuclein inclusion formation during aging. PLoS Genet. 4, 10000027.
37. Ved, R., Saha, S., Westlund, B., Perier, C., Burnam, L., Sluder, A., Hoener, M., Rodrigues, C. M., Alfonso, A., Steer, C. et al. (2005). Similar patterns, of, mitochondrial vulnerability and rescue induced by genetic modification of alpha-synuclein parkin and DJ- 1 in Caenorhabditis elegans. J. Biol. Chem. 280, 42655-42668. (Pubitemid 43049224)
38. West, A. B., Moore, D. J., Choi, C., Andrabi, S. A., Li, X., Dikeman, D., Biskup, S., Zhang, Z., Lim, K. L., Dawson, V. L. and Dawson, T. M. (2007). Parkinson's disease-associated mutations in LRRK2 link enhanced GTP-binding and kinase activities to neuronal toxicity. Hum. Mol. Genet. 16, 223-232. (Pubitemid 46179004)
39. Wolozin, B., Saha, S., Guillily, M., Ferree, A. and Riley, M. (2008). Investigating convergent actions of genes linked to familial Parkinson's disease. Neurodegener Dis. 5, 182-185. (Pubitemid 351347845)